**Core Concept**
Acute symptomatic sinus bradycardia is a condition characterized by a slow heart rate (less than 60 beats per minute) originating from the sinoatrial (SA) node, often causing symptoms such as dizziness, fatigue, and shortness of breath. The underlying pathophysiology involves impaired cardiac conduction and/or SA node dysfunction.

**Why the Correct Answer is Right**
In acute symptomatic sinus bradycardia, the primary goal is to increase the heart rate to alleviate symptoms. Atropine, a muscarinic receptor antagonist, is the preferred initial treatment. Atropine works by blocking the action of acetylcholine on the SA node, thereby increasing the heart rate. It is effective in 80-90% of cases, making it a first-line treatment.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it is not a standard first-line treatment for acute symptomatic sinus bradycardia. While dopamine and dobutamine can increase heart rate, they are typically reserved for more severe cases and are not the initial treatment of choice.
**Option B:** This option is incorrect as it is a medication used to slow heart rate, not increase it. Beta-blockers are contraindicated in acute symptomatic sinus bradycardia as they can worsen the condition.
**Option C:** This option is incorrect as it is not a standard treatment for acute symptomatic sinus bradycardia. While pacing can be used in certain cases, it is not the initial treatment of choice.

**Clinical Pearl / High-Yield Fact**
Remember the "ATROPINE" mnemonic for acute symptomatic sinus bradycardia treatment: A - Atropine, T - Transcutaneous pacing, R - Reversal of offending medication, O - Oxygen therapy, P - Phosphate supplementation, I - Intravenous fluids, N - Naloxone (if opioid-induced), E - Electrocardiogram monitoring.

**Correct Answer: A. Atropine**